Inventor · disambiguated record
Peter Henry Milner
Also filed as: MILNER PETER H · MILNER PETER HENRY
15 granted patents·4 pending applications·194 citations·filing 1981–2005
93Inventor score
Files withBEECHAM GROUP PLC6SMITHKLINE BEECHAM PLC4AFFINIUM PHARM INC3BEECHAM GROUP LTD2GLAXO GROUP LTD2
Top patents by PatentIndex Score
19 records- 0193US7253198B2Hydroxyethylamine derivatives for the treatment of Alzheimer's diseaseGLAXO GROUP LTD·Filed 2003·Granted Aug 7, 2007·70 cites·16 claims
- 0285US6992103B2Benzamide derivatives, processes for their preparation, and their pharmaceutical useSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 31, 2006·30 cites·25 claims
- 0375US6995254B1Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB IAFFINIUM PHARM INC·Filed 1997·Granted Feb 7, 2006·34 cites·8 claims
- 0475US4539149Aβ-Lactam antibacterial agentsBEECHAM GROUP PLC·Filed 1982·Granted Sep 3, 1985·7 cites·34 claims
- 0567US6432670B1Polynucleotides encoding staphylcoccal FAB I enoyl-ACP reductaseSMITHKLINE BEECHAM CORP·Filed 1999·Granted Aug 13, 2002·22 cites·12 claims
- 0664US4609652AMethods of using β-lactam antibacterial agentsBEECHAM GROUP PLC·Filed 1985·Granted Sep 2, 1986·5 cites·32 claims
- 0757US4877783Aβ-lactam antibacterial agentsBEECHAM GROUP PLC·Filed 1985·Granted Oct 31, 1989·3 cites·34 claims
- 0855US4670431ABeta-lactam antibacterial agentsBEECHAM GROUP PLC·Filed 1984·Granted Jun 2, 1987·3 cites·19 claims
- 0955US2005112713A1Methods of using Fab I and compounds modulating Fab I activityAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1054US6753172B1FabIAFFINIUM PHARM INC·Filed 1999·Granted Jun 22, 2004·11 cites·13 claims
- 1150US2004209822A1Novel compoundsSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1248US4555363AProcess for the preparation of β-lactam compoundsBEECHAM GROUP PLC·Filed 1984·Granted Nov 26, 1985·2 cites·9 claims
- 1347US4349551APenicillin derivatives and compositions containing themBEECHAM GROUP LTD·Filed 1981·Granted Sep 14, 1982·2 cites·11 claims
- 1441US7160905B2Hydroxyethylene compounds with Asp2 inhibitory activitySMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 9, 2007·0 cites·4 claims
- 1541US2003207923A12,'3-Amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitorsFiled 2000·Application pending·0 cites
- 1641US2008318933A15-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1740US4394375ACephalosporin derivatives, and compositions containing themBEECHAM GROUP LTD·Filed 1981·Granted Jul 19, 1983·2 cites·13 claims
- 1839US4661480AFormamido oxacephemsBEECHAM GROUP PLC·Filed 1984·Granted Apr 28, 1987·1 cites·12 claims
- 1930US6458779B1Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF releaseSMITHKLINE BEECHAM PLC·Filed 1999·Granted Oct 1, 2002·2 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →